Get the Stockscreener App
55.08
0.64%
0.43
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $55.08, with a volume of 5.67M.
It is up +0.64% in the last 24 hours and down -14.85% over the past month.
See More
Previous Close:
$54.65
Open:
$54.5
24h Volume:
5.67M
Relative Volume:
0.59
Market Cap:
$72.42B
Revenue:
$363.25B
Net Income/Loss:
$7.19B
P/E Ratio:
8.3077
EPS:
6.63
Net Cash Flow:
$5.27B
1W Performance:
-2.22%
1M Performance:
-14.85%
6M Performance:
-1.61%
1Y Performance:
-21.71%
1-Day Range:
$54.31
$55.16
1-Week Range:
$54.31
$57.32
52-Week Range:
$52.77
$83.25
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
Wall Street looking for CVS to show execution plan - MSN
CVS Health Tackles Medicare Costs As Investors Demand Change - Finimize
Wall Street looking for CVS to show execution plan By Reuters - Investing.com
Wall Street Looking for CVS to Show Execution Plan - U.S News & World Report Money
In the wake of CVS Health Corporation's (NYSE:CVS) latest US$3.4b market cap drop, institutional owners may be forced to take severe actions - Yahoo Finance
CVS Health Co. (NYSE:CVS) Shares Bought by Van ECK Associates Corp - MarketBeat
CVS Health Co. (NYSE:CVS) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Analysts Still Bullish on CVS Ahead of Earnings Despite Recent Stock Drop - Yahoo Finance
CVS faces credit rating reviewBizwomen - The Business Journals
HIV-Positive Individuals Seek to Certify a Class Action in Discrimination Case Against CVS, Says Consumer Watchdog - Yahoo Finance
CVS Health Q3 Earnings Preview: Can The Company Overcome Recent Challenges? - Benzinga
Wells Fargo & Company Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat
CVS faces credit rating review as debt leverage climbs - The Business Journals
Mn Services Vermogensbeheer B.V. Decreases Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
1 Stock to Buy, 1 Stock to Sell This Week: Arista Networks, CVS Health - Yahoo Finance
1 Stock to Buy, 1 Stock to Sell This Week: Arista Networks, CVS Health - Investing.com
US Bancorp DE Cuts Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Stock: Analyst Estimates & Ratings - Barchart
Willow Grove man charged with insider trading after making $617K on CVS Health deal - Glenside Local
Curious about CVS Health (CVS) Q3 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
Willow Grove man faces insider trading charges after CVS-Oak Street deal - The Philadelphia Inquirer
CVS Unit Exec's Ex-Partner Charged With Insider Trading - Law360
Scientist Charged With Trading on Domestic Partner’s Deal Secret - Bloomberg
SEC Sues Scientist for Insider Trading in CVS-Oak Street Merger - Bloomberg Law
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Pennsylvania man charged with insider trading related to CVS takeover - MSN
Pennsylvania man charged with insider trading related to CVS takeover By Reuters - Investing.com
CVS Credit Rating at Risk After Growth Gamble Fails to Pay Off - Yahoo Finance
CVS Health Corporation (CVS): Among The 10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
CVS Health Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
10 Oversold Blue Chip Stocks to Buy Now - Insider Monkey
Earnings Preview: CVS Health (CVS) Q3 Earnings Expected to Decline - Yahoo Finance
CVS Health Insider Lowered Holding By 40% During Last Year - Yahoo Finance
CVS Health (CVS) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
CVS Health Corporation (CVS): Is This High Growth Retail Stock Profitable in 2024? - Insider Monkey
Bridging the Gap: Innovations in Rural Healthcare Access Worldwide - Healthcare Digital
Mirae Asset Global Investments Co. Ltd. Sells 8,763 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) the Most Profitable Value Stock To Invest In? - Insider Monkey
CVS needs ‘realistic targets’ it can exceed says analyst after CEO dismissal - Yahoo Finance
CVS appoints new CEO amid restructuring - The Ticker
DekaBank Deutsche Girozentrale Has $113.86 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS CEO Exit Ends Promising Era of Women Heading Pharmacy Chains - MSN
CVS Caremark Q1 Earnings Top EstimatesUpdate - RTTNews
CVS Caremark To Report Q4 Results: Earnings Preview - RTTNews
CVS Caremark Q4 Profit Slightly Down; Adj. EPS Tops ViewUpdate - RTTNews
CVS Caremark Q3 Profit Rises; Lifts FY11 EPS ViewUpdate - RTTNews
CVS Caremark Operating Chief Merlo To Become CEO In March - RTTNews
CVS Caremark Q4 Results Tops Estimates, Lifts 2013 Outlook - RTTNews
CVS names Joyner as CEO under investor pressure, withdraws profit forecast - MSN
International Assets Investment Management LLC Buys 1,133,184 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):